Abstract:Context - MicroRNAs (miRNAs) represent a class of small non-coding RNAs that regulate the gene expressions at the posttranscriptional level, subsequently control crucial physiological processes. Recent evidence demonstrates that some miRNAs have the functions similar to oncogene or tumor suppressors, It may play important roles in tumorigenesis MiRNA expression profiles may become useful biomarkers for cancer diagnostics, prognosis and prediction of response to treatment, and it could be a powerful tool for cancer prevention and therapeuticsObjective - To explore the global expression profile of miRNAs in non small cell lung cancer (NSCLC) and its potential relevance to clinicopathological characteristics and prognosis.Methods. - LNA microRNA microarrays were utilized to detect miRNA expression levels in eight surgically removed lung carcinoma tissues (La) and their corresponding normal lung tissues (NT) After initial microarray validation by quantitative real-time reverse transcription polymerase chain reaction assays (qRT-PCR), miR-21, miR-143 and miR-181a were selected for further study in another 47 paired LCTs and matched NTs by qRT-PCR using Taqman microRNA assay.Results. - Twenty-seven microRNAs were observed to be deregulated greater than two-fold in LCT compared with NT by microarray. Consistenting with the microarray, the expression level of miR-21 by qRT-PCR was significantly higher in tumor tissues than in adjacent normal tissues (P = 0026); while miR-143 (P = 0.000) and miR-181a (P= 0.000) were downregulated in LCT. Interestingly, among the 47 NSCLC cases, low level expression of miR-143 was significantly correlated with smoking status (P= 0026), high miR-21 expression (hazard ratio, 5993, 95% confidence interval, 2 518-14.264; P= 0.000) and low miR-181a expression (hazard ratio, 0.328, 95% confidence interval 0.142-0 756; P = 0.009) were associated with poor survival, independent of clinical covariates. including TNM staging, lymph note status.Conclusion. - Our data thus indicating the potential of miR-21, miR-143 and miR-181a as a novel diagnostic or prognostic biomarker for NSCLC. Besides, these data will guide further studies of specific microRNAs might become potential targets for therapeutic intervention. (C) 2010 Elsevier Masson SAS All rights reserved.

Expression of miRNA-29s in non-small cell lung cancer and its clinical significance

Expression of miRNA-29a in non-small cell lung cancer and clinical significance

Analysis of Genetic Variants and the Cerna Network of Mir-9 in Non-Small Cell Lung Cancer

Prognostic Value of the MicroRNA‐29 Family in Multiple Human Cancers: A Meta‐analysis and Systematic Review

Identification of miRNA Biomarkers for Non-small Cell Lung Cancer using Microarray Datasets and Bioinformatics Analysis

Expression and clinical significance of microRNA-29b in the epithelian ovarian cancer

Deregulated Expression of Mir-21, Mir-143 and Mir-181A in Non Small Cell Lung Cancer is Related to Clinicopathologic Characteristics or Patient Prognosis

A Genetic Polymorphism In Pre-Mir-27a Confers Clinical Outcome Of Non-Small Cell Lung Cancer In A Chinese Population

High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer

Change in Expressional Level and Clinicopathological Significance of Mir-193B-3p in Non-Small Cell Lung Cancer.

Up-Regulation Of Microrna-93 Predicates Advanced Clinicopathological Features And Serves As An Unfavorable Risk Factor For Survival Of Patients With Non-Small Cell Lung Cancer

miR-29a/b Enhances Cell Migration and Invasion in Nasopharyngeal Carcinoma Progression by Regulating SPARC and COL3A1 Gene Expression

MiRNA-195-5p Functions As a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1

Investigation of Targeting Relationship Between Micro-Rna-22 and Vegfr3 in Lung Squamous Cell Carcinoma

Downregulation of Mir-138 Predicts Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma.

Down-regulation of Microrna-144-3p and Its Clinical Value in Non-Small Cell Lung Cancer: a Comprehensive Analysis Based on Microarray, Mirna-Sequencing, and Quantitative Real-Time PCR Data

The Clinical Value of Mir‐193a‐3p in Non‐small Cell Lung Cancer and Its Potential Molecular Mechanism Explored in Silico Using RNA‐sequencing and Microarray Data

Prognostic significance of serum miRNA-21 expression in human non-small cell lung cancer.

Decreased Expression Of Mir-32 Is Associated With The Clinical Outcome Of Non-Small Cell Lung Cancer Patients

Expression of Mir-150 and Mir-3940-5p is Reduced in Non-Small Cell Lung Carcinoma and Correlates with Clinicopathological Features

Down-Regulation of Mir-452 is Associated with Poor Prognosis in the Non-Small-Cell Lung Cancer